News | June 20, 2022
Aurobindo Pharma board approves acquisition of GLS Pharma
The company has a total sales of Rs. 25.8 crore during FY 21-22 and Rs. 26.4 crore during FY 20-21.
The company has a total sales of Rs. 25.8 crore during FY 21-22 and Rs. 26.4 crore during FY 20-21.
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
Glenmark is the first company in India to market the innovative FDC of Indacaterol
Many kids who have heart transplants live a normal, healthy life once they recover from surgery.
63-year old woman gets rare Transcatheter Tricuspid Valve Replacement (TTVR)
SPLASH also houses the tools’ calibration for epMotion, Eppendorf automated liquid handling workstations.
Nippon Express has provided a pharmaceutical distribution platform with strict temperature control in two ranges -- 2 C to 8 C
We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”
This MoU will further strengthen relations between India and the USA within the framework of international scientific and technological cooperation in fields of mutual interest.
The company has posted net profit of Rs.39.71 crores for the Financial Year ended March 31, 2022.
Subscribe To Our Newsletter & Stay Updated
